Tourmaline Historical Financial Ratios
| TRML Stock | 18.86 0.63 3.46% |
Tourmaline Bio is promptly reporting on over 72 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 11.25, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.0 will help investors to properly organize and evaluate Tourmaline Bio financial condition quickly.
Tourmaline | Build AI portfolio with Tourmaline Stock |
About Tourmaline Financial Ratios Analysis
Tourmaline BioFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Tourmaline Bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Tourmaline financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Tourmaline Bio history.
Tourmaline Bio Financial Ratios Chart
Add Fundamental
Dividend Yield
Dividend Yield is Tourmaline Bio dividend as a percentage of Tourmaline Bio stock price. Tourmaline Bio dividend yield is a measure of Tourmaline Bio stock productivity, which can be interpreted as interest rate earned on an Tourmaline Bio investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Tourmaline Bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Tourmaline Bio current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.At this time, Tourmaline Bio's Company Equity Multiplier is quite stable compared to the past year. Total Debt To Capitalization is expected to rise to 0.0009 this year, although the value of Free Cash Flow Yield will most likely fall to (0.16).
| 2023 | 2024 | 2025 (projected) | Current Ratio | 41.76 | 30.18 | 18.74 | Net Debt To EBITDA | 3.09 | 0.34 | 0.32 |
Tourmaline Bio fundamentals Correlations
Click cells to compare fundamentals
Tourmaline Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tourmaline Bio fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 0.73 | (7.4K) | (10.51) | 0.61 | 1.71 | 1.8 | |
| Book Value Per Share | 221.4 | (0.0208) | (0.97) | 43.19 | 11.84 | 11.25 | |
| Free Cash Flow Yield | (0.19) | (0.0255) | (0.0556) | (0.23) | (0.15) | (0.16) | |
| Operating Cash Flow Per Share | (28.74) | (3.68) | (0.32) | (5.92) | (3.05) | (3.2) | |
| Capex To Depreciation | 2.88 | 3.91 | 844.67 | 1.7 | 0.23 | 0.22 | |
| Pb Ratio | 0.73 | (7.4K) | (10.51) | 0.61 | 1.71 | 1.8 | |
| Free Cash Flow Per Share | (30.66) | (3.9) | (0.57) | (5.93) | (3.05) | (3.2) | |
| Roic | (0.15) | 9.77 | (2.49) | (0.22) | (0.3) | (0.28) | |
| Net Income Per Share | (33.97) | (8.3E-5) | (0.97) | (8.87) | (2.89) | (3.03) | |
| Cash Per Share | 223.62 | 20.74 | 0.41 | 42.75 | 10.19 | 9.68 | |
| Pocfratio | (5.65) | (41.58) | (32.12) | (4.43) | (6.65) | (6.99) | |
| Capex To Operating Cash Flow | (0.0669) | (0.0609) | (0.78) | (0.001994) | (1.16E-4) | (1.22E-4) | |
| Pfcf Ratio | (5.3) | (39.19) | (18.0) | (4.42) | (6.65) | (6.99) | |
| Income Quality | 0.85 | 0.84 | 0.33 | 0.67 | 1.06 | 0.86 | |
| Roe | (0.15) | 0.004 | 1.0 | (0.21) | (0.24) | (0.23) | |
| Ev To Operating Cash Flow | (4.74) | (41.58) | (30.92) | 0.57 | (6.26) | (6.57) | |
| Pe Ratio | (4.78) | (1.8M) | (10.53) | (2.95) | (7.02) | (7.37) | |
| Return On Tangible Assets | (0.15) | (0.006027) | (2.17) | (0.2) | (0.24) | (0.25) | |
| Ev To Free Cash Flow | (4.44) | (39.19) | (17.32) | 0.57 | (6.26) | (6.57) | |
| Earnings Yield | (0.21) | (1.0E-6) | (0.095) | (0.34) | (0.14) | (0.15) | |
| Current Ratio | 44.29 | 0.4 | 6.1 | 41.76 | 30.18 | 18.74 | |
| Tangible Book Value Per Share | 221.4 | (0.0208) | (0.97) | 43.19 | 11.84 | 11.25 | |
| Shareholders Equity Per Share | 221.4 | (0.0208) | (0.97) | 43.19 | 11.84 | 11.25 | |
| Capex Per Share | 1.92 | 0.22 | 0.25 | 0.0118 | 3.55E-4 | 3.37E-4 | |
| Graham Net Net | 216.48 | 20.7 | (1.01) | 41.65 | 9.84 | 9.35 | |
| Enterprise Value Over E B I T D A | (4.09) | (35.47) | (10.14) | 0.35 | (5.39) | (5.66) | |
| Price Earnings Ratio | (4.78) | (1.8M) | (10.53) | (2.95) | (7.02) | (7.37) | |
| Price Book Value Ratio | 0.73 | (7.4K) | (10.51) | 0.61 | 1.71 | 1.8 | |
| Price To Operating Cash Flows Ratio | (5.65) | (41.58) | (32.12) | (4.43) | (6.65) | (6.99) | |
| Price To Free Cash Flows Ratio | (5.3) | (39.19) | (18.0) | (4.42) | (6.65) | (6.99) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.